The last 200 years have seen extraordinary changes in the technologies used for molecular biology research and diagnostics, but the conventional pathology workflow is basically the same as it was in the 1800s. Pathology looks more like an art form than a science: subjective, qualitative, and manual.
This lack of innovation in histology and pathology leads to real-life consequences for patients. Widespread sampling bias leads to missed and misdiagnosis, putting lives at risk. It has implications at the societal level, too. Irreproducible research contributes to an estimated $28 billion in costs every year.
3Scan’s technology brings precision, repeatability, and analysis to pathology for the first time, delivering the insights both patients and society needs.